Table of Contents
Global Influenzavirus B Infection Drug Market Research Report 2021
1 Influenzavirus B Infection Drug Market Overview
1.1 Product Overview and Scope of Influenzavirus B Infection Drug
1.2 Influenzavirus B Infection Drug Segment by Type (Product Category)
1.2.1 Global Influenzavirus B Infection Drug Production and CAGR (%) Comparison by Type (Product Category)(2016 - 2027)
1.2.2 Global Influenzavirus B Infection Drug Production Market Share by Type (Product Category) in 2017
1.2.3 APP - 309
1.2.4 CF - 403
1.2.5 GC - 3106A
1.2.6 KIN - 1400
1.2.7 Others
1.3 Global Influenzavirus B Infection Drug Segment by Application
1.3.1 Influenzavirus B Infection Drug Consumption (Sales) Comparison by Application (2016 - 2027)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Influenzavirus B Infection Drug Market by Region (2016 - 2027)
1.4.1 Global Influenzavirus B Infection Drug Market Size (Value) and CAGR (%) Comparison by Region (2016 - 2027)
1.4.2 North America Status and Prospect (2016 - 2027)
1.4.3 Europe Status and Prospect (2016 - 2027)
1.4.4 China Status and Prospect (2016 - 2027)
1.4.5 Japan Status and Prospect (2016 - 2027)
1.4.6 Southeast Asia Status and Prospect (2016 - 2027)
1.4.7 India Status and Prospect (2016 - 2027)
1.5 Global Market Size (Value) of Influenzavirus B Infection Drug (2016 - 2027)
1.5.1 Global Influenzavirus B Infection Drug Revenue Status and Outlook (2016 - 2027)
1.5.2 Global Influenzavirus B Infection Drug Capacity, Production Status and Outlook (2016 - 2027)
2 Global Influenzavirus B Infection Drug Market Competition by Manufacturers
2.1 Global Influenzavirus B Infection Drug Capacity, Production and Share by Manufacturers (2016 - 2021)
2.1.1 Global Influenzavirus B Infection Drug Capacity and Share by Manufacturers (2016 - 2021)
2.1.2 Global Influenzavirus B Infection Drug Production and Share by Manufacturers (2016 - 2021)
2.2 Global Influenzavirus B Infection Drug Revenue and Share by Manufacturers (2016 - 2021)
2.3 Global Influenzavirus B Infection Drug Average Price by Manufacturers (2016 - 2021)
2.4 Manufacturers Influenzavirus B Infection Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Influenzavirus B Infection Drug Market Competitive Situation and Trends
2.5.1 Influenzavirus B Infection Drug Market Concentration Rate
2.5.2 Influenzavirus B Infection Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Influenzavirus B Infection Drug Capacity, Production, Revenue (Value) by Region (2016 - 2021)
3.1 Global Influenzavirus B Infection Drug Capacity and Market Share by Region (2016 - 2021)
3.2 Global Influenzavirus B Infection Drug Production and Market Share by Region (2016 - 2021)
3.3 Global Influenzavirus B Infection Drug Revenue (Value) and Market Share by Region (2016 - 2021)
3.4 Global Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.5 North America Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.6 Europe Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.7 China Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.8 Japan Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.9 Southeast Asia Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
3.10 India Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
4 Global Influenzavirus B Infection Drug Supply (Production), Consumption, Export, Import by Region (2016 - 2021)
4.1 Global Influenzavirus B Infection Drug Consumption by Region (2016 - 2021)
4.2 North America Influenzavirus B Infection Drug Production, Consumption, Export, Import (2016 - 2021)
4.3 Europe Influenzavirus B Infection Drug Production, Consumption, Export, Import (2016 - 2021)
4.4 China Influenzavirus B Infection Drug Production, Consumption, Export, Import (2016 - 2021)
4.5 Japan Influenzavirus B Infection Drug Production, Consumption, Export, Import (2016 - 2021)
4.6 Southeast Asia Influenzavirus B Infection Drug Production, Consumption, Export, Import (2016 - 2021)
4.7 India Influenzavirus B Infection Drug Production, Consumption, Export, Import (2016 - 2021)
5 Global Influenzavirus B Infection Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Influenzavirus B Infection Drug Production and Market Share by Type (2016 - 2021)
5.2 Global Influenzavirus B Infection Drug Revenue and Market Share by Type (2016 - 2021)
5.3 Global Influenzavirus B Infection Drug Price by Type (2016 - 2021)
5.4 Global Influenzavirus B Infection Drug Production Growth by Type (2016 - 2021)
6 Global Influenzavirus B Infection Drug Market Analysis by Application
6.1 Global Influenzavirus B Infection Drug Consumption and Market Share by Application (2016 - 2021)
6.2 Global Influenzavirus B Infection Drug Consumption Growth Rate by Application (2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Influenzavirus B Infection Drug Manufacturers Profiles/Analysis
7.1 AbbVie Inc
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AbbVie Inc Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Adimmune Corp
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Adimmune Corp Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Altravax Inc
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Altravax Inc Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Amarillo Biosciences Inc
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Amarillo Biosciences Inc Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Aphios Corp
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Aphios Corp Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2015 - 2021)
7.5.4 Main Business/Business Overview
7.6 BioCryst Pharmaceuticals Inc
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Cadila Healthcare Ltd
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Cadila Healthcare Ltd Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 ContraFect Corp
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 ContraFect Corp Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Daiichi Sankyo Company Ltd
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2021)
7.9.4 Main Business/Business Overview
7.10 Fujifilm Holdings Corporation
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Influenzavirus B Infection Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Capacity, Production, Revenue, Price and Gross Margin (2016 - 2020)
7.10.4 Main Business/Business Overview
7.11 GlaxoSmithKline Plc
7.12 Green Cross Corp
7.13 Inovio Pharmaceuticals Inc
7.14 Kineta Inc
7.15 Medicago Inc
7.16 MedImmune LLC
7.17 Mucosis BV
7.18 Novavax Inc
7.19 Park Active Molecules
7.20 Romark Laboratories LC
7.21 Sanofi
7.22 Sanofi Pasteur SA
7.23 Shionogi & Co Ltd
7.24 SK Chemicals Co Ltd
7.25 TSRL Inc
7.26 Vaxart Inc
7.27 Vectura Group Plc
8 Influenzavirus B Infection Drug Manufacturing Cost Analysis
8.1 Influenzavirus B Infection Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Influenzavirus B Infection Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Influenzavirus B Infection Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Influenzavirus B Infection Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Influenzavirus B Infection Drug Market Forecast (2021 - 2027)
12.1 Global Influenzavirus B Infection Drug Capacity, Production, Revenue Forecast (2021 - 2027)
12.1.1 Global Influenzavirus B Infection Drug Capacity, Production and Growth Rate Forecast (2021 - 2027)
12.1.2 Global Influenzavirus B Infection Drug Revenue and Growth Rate Forecast (2021 - 2027)
12.1.3 Global Influenzavirus B Infection Drug Price and Trend Forecast (2021 - 2027)
12.2 Global Influenzavirus B Infection Drug Production, Consumption , Import and Export Forecast by Region (2021 - 2027)
12.2.1 North America Influenzavirus B Infection Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.2 Europe Influenzavirus B Infection Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.3 China Influenzavirus B Infection Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.4 Japan Influenzavirus B Infection Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.5 Southeast Asia Influenzavirus B Infection Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.2.6 India Influenzavirus B Infection Drug Production, Revenue, Consumption, Export and Import Forecast (2021 - 2027)
12.3 Global Influenzavirus B Infection Drug Production, Revenue and Price Forecast by Type (2021 - 2027)
12.4 Global Influenzavirus B Infection Drug Consumption Forecast by Application (2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Influenzavirus B Infection Drug
Figure Global Influenzavirus B Infection Drug Production () and CAGR (%) Comparison by Types (Product Category) (2016 - 2027)
Figure Global Influenzavirus B Infection Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of APP - 309
Table Major Manufacturers of APP - 309
Figure Product Picture of CF - 403
Table Major Manufacturers of CF - 403
Figure Product Picture of GC - 3106A
Table Major Manufacturers of GC - 3106A
Figure Product Picture of KIN - 1400
Table Major Manufacturers of KIN - 1400
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Influenzavirus B Infection Drug Consumption (K Pcs) by Applications (2016 - 2027)
Figure Global Influenzavirus B Infection Drug Consumption Market Share by Applications in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Influenzavirus B Infection Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2016 - 2027)
Figure North America Influenzavirus B Infection Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Europe Influenzavirus B Infection Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure China Influenzavirus B Infection Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Japan Influenzavirus B Infection Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Southeast Asia Influenzavirus B Infection Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure India Influenzavirus B Infection Drug Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Influenzavirus B Infection Drug Revenue (Million USD) Status and Outlook (2016 - 2027)
Figure Global Influenzavirus B Infection Drug Capacity, Production (K Pcs) Status and Outlook (2016 - 2027)
Figure Global Influenzavirus B Infection Drug Major Players Product Capacity (K Pcs) (2016 - 2021)
Table Global Influenzavirus B Infection Drug Capacity (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Influenzavirus B Infection Drug Capacity Market Share of Key Manufacturers (2016 - 2021)
Figure Global Influenzavirus B Infection Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Influenzavirus B Infection Drug Capacity (K Pcs) of Key Manufacturers in 2021
Figure Global Influenzavirus B Infection Drug Major Players Product Production (K Pcs) (2016 - 2021)
Table Global Influenzavirus B Infection Drug Production (K Pcs) of Key Manufacturers (2016 - 2021)
Table Global Influenzavirus B Infection Drug Production Share by Manufacturers (2016 - 2021)
Figure 2017 Influenzavirus B Infection Drug Production Share by Manufacturers
Figure 2017 Influenzavirus B Infection Drug Production Share by Manufacturers
Figure Global Influenzavirus B Infection Drug Major Players Product Revenue (Million USD) (2016 - 2021)
Table Global Influenzavirus B Infection Drug Revenue (Million USD) by Manufacturers (2016 - 2021)
Table Global Influenzavirus B Infection Drug Revenue Share by Manufacturers (2016 - 2021)
Table 2017 Global Influenzavirus B Infection Drug Revenue Share by Manufacturers
Table 2021 Global Influenzavirus B Infection Drug Revenue Share by Manufacturers
Table Global Market Influenzavirus B Infection Drug Average Price (USD/Pcs) of Key Manufacturers (2016 - 2021)
Figure Global Market Influenzavirus B Infection Drug Average Price (USD/Pcs) of Key Manufacturers in 2017
Table Manufacturers Influenzavirus B Infection Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Influenzavirus B Infection Drug Product Category
Figure Influenzavirus B Infection Drug Market Share of Top 3 Manufacturers
Figure Influenzavirus B Infection Drug Market Share of Top 5 Manufacturers
Table Global Influenzavirus B Infection Drug Capacity (K Pcs) by Region (2016 - 2021)
Figure Global Influenzavirus B Infection Drug Capacity Market Share by Region (2016 - 2021)
Figure Global Influenzavirus B Infection Drug Capacity Market Share by Region (2016 - 2021)
Figure 2017 Global Influenzavirus B Infection Drug Capacity Market Share by Region
Table Global Influenzavirus B Infection Drug Production by Region (2016 - 2021)
Figure Global Influenzavirus B Infection Drug Production (K Pcs) by Region (2016 - 2021)
Figure Global Influenzavirus B Infection Drug Production Market Share by Region (2016 - 2021)
Figure 2017 Global Influenzavirus B Infection Drug Production Market Share by Region
Table Global Influenzavirus B Infection Drug Revenue (Million USD) by Region (2016 - 2021)
Table Global Influenzavirus B Infection Drug Revenue Market Share by Region (2016 - 2021)
Figure Global Influenzavirus B Infection Drug Revenue Market Share by Region (2016 - 2021)
Table 2017 Global Influenzavirus B Infection Drug Revenue Market Share by Region
Figure Global Influenzavirus B Infection Drug Capacity, Production (K Pcs) and Growth Rate (2016 - 2021)
Table Global Influenzavirus B Infection Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table North America Influenzavirus B Infection Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Europe Influenzavirus B Infection Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table China Influenzavirus B Infection Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Japan Influenzavirus B Infection Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table China Influenzavirus B Infection Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016 - 2021)
Table Japan Influenzavirus B In
